In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The agency says the companies artificially inflated insulin list prices that resulted in patients paying more for the medications. The companies are CVS Health’s Caremark RX, Cigna’s Express Scripts, ...